TrialBMC cancer2014

Sunitinib in combination with trastuzumab for the treatment of advanced breast cancer: activity and safety results from a phase II study.

Thomas Bachelot et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.